ALIMERA SCIENCES INC Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alimera Sciences Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Alimera Sciences Inc Return On Equity for the quarter ending June 30, 2024 was -33.7 %, a 104% decline year-over-year.
  • Alimera Sciences Inc annual Return On Equity for 2023 was -65.8 %, a 154% decline from 2022.
  • Alimera Sciences Inc annual Return On Equity for 2022 was 121 %, a 50.3% decline from 2021.
  • Alimera Sciences Inc annual Return On Equity for 2021 was 244 %, a 226% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -33.7 -864 -104% Apr 1, 2024 Jun 30, 2024
Q1 2024 -47.1 -145 -148% Jan 1, 2024 Mar 31, 2024
Q4 2023 -65.8 -187 -154% Oct 1, 2023 Dec 31, 2023
Q3 2023 -145 -323 -182% Jul 1, 2023 Sep 30, 2023
Q2 2023 831 +516 +164% Apr 1, 2023 Jun 30, 2023
Q1 2023 97.6 -603 -86.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 121 -123 -50.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 177 +138 +347% Jul 1, 2022 Sep 30, 2022
Q2 2022 315 +358 Apr 1, 2022 Jun 30, 2022
Q1 2022 700 +612 +689% Jan 1, 2022 Mar 31, 2022
Q4 2021 244 +169 +226% Oct 1, 2021 Dec 31, 2021
Q3 2021 39.6 -22.2 -35.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -42.8 -150 -140% Apr 1, 2021 Jun 30, 2021
Q1 2021 88.8 -88.7 -50% Jan 1, 2021 Mar 31, 2021
Q4 2020 74.8 -224 -75% Oct 1, 2020 Dec 31, 2020
Q3 2020 61.8 -656 -91.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 107 +1.99K Apr 1, 2020 Jun 30, 2020
Q1 2020 178 +563 Jan 1, 2020 Mar 31, 2020
Q4 2019 299 +631 Oct 1, 2019 Dec 31, 2019
Q3 2019 718 +998 Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.88K -1.69K -868% Apr 1, 2019 Jun 30, 2019
Q1 2019 -386 -247 -177% Jan 1, 2019 Mar 31, 2019
Q4 2018 -331 -218 -192% Oct 1, 2018 Dec 31, 2018
Q3 2018 -280 -186 -198% Jul 1, 2018 Sep 30, 2018
Q2 2018 -194 -93.1 -91.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -139 -7.71 -5.86% Jan 1, 2018 Mar 31, 2018
Q4 2017 -114 +43.8 +27.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -94 +84.6 +47.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -101 +35.7 +26% Apr 1, 2017 Jun 30, 2017
Q1 2017 -132 -15.1 -12.9% Jan 1, 2017 Mar 31, 2017
Q4 2016 -157 -65.6 -71.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -179 -104 -140% Jul 1, 2016 Sep 30, 2016
Q2 2016 -137 -31.7 -30.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -116 -27.4 -30.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -91.8 +83.3 +47.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -74.5 +526 +87.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -105 +392 +78.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -89.1 +763 +89.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -175 +287 +62.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -600 -425 -243% Jul 1, 2014 Sep 30, 2014
Q2 2014 -497 -308 -162% Apr 1, 2014 Jun 30, 2014
Q1 2014 -852 -726 -578% Jan 1, 2014 Mar 31, 2014
Q4 2013 -463 -374 -420% Oct 1, 2013 Dec 31, 2013
Q3 2013 -175 -64.8 -58.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -189 -96.6 -104% Apr 1, 2013 Jun 30, 2013
Q1 2013 -126 -47.2 -60.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -89 Oct 1, 2012 Dec 31, 2012
Q3 2012 -110 Jul 1, 2012 Sep 30, 2012
Q2 2012 -92.8 Apr 1, 2012 Jun 30, 2012
Q1 2012 -78.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.